1. Home
  2. WNC vs VNDA Comparison

WNC vs VNDA Comparison

Compare WNC & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WNC

Wabash National Corporation

HOLD

Current Price

$12.89

Market Cap

325.8M

Sector

Industrials

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$6.26

Market Cap

361.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WNC
VNDA
Founded
1985
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
325.8M
361.4M
IPO Year
2009
2005

Fundamental Metrics

Financial Performance
Metric
WNC
VNDA
Price
$12.89
$6.26
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$11.00
$14.90
AVG Volume (30 Days)
976.1K
905.2K
Earning Date
05-01-2026
05-06-2026
Dividend Yield
3.84%
N/A
EPS Growth
179.22
N/A
EPS
N/A
N/A
Revenue
$2,027,489,000.00
$216,105,000.00
Revenue This Year
$10.65
$21.35
Revenue Next Year
$14.06
$37.40
P/E Ratio
N/A
N/A
Revenue Growth
8.81
8.72
52 Week Low
$6.63
$4.14
52 Week High
$14.32
$9.91

Technical Indicators

Market Signals
Indicator
WNC
VNDA
Relative Strength Index (RSI) 65.69 51.73
Support Level $8.34 $5.97
Resistance Level $12.94 $6.73
Average True Range (ATR) 0.71 0.21
MACD -0.16 0.07
Stochastic Oscillator 50.68 54.72

Price Performance

Historical Comparison
WNC
VNDA

About WNC Wabash National Corporation

Wabash National Corp operates as the innovation leader of connected solutions for the transportation, logistics, and distribution industries. The Company manages its business in two operating and reportable segments: Transportation Solutions and Parts & Services. It designs and manufactures products including dry freight and refrigerated trailers, platform trailers, tank trailers, dry and refrigerated truck bodies, structural composite panels and products, trailer aerodynamic solutions, and specialty food-grade processing equipment.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: